The role of therapeutic drug monitoring in treatment of HIV infection

被引：44

作者：

Back, DJ

Khoo, SH

Gibbons, SE

Merry, C

机构：

[1] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England

[2] Northwestern Univ, Sch Med, Comprehens AIDS Ctr, Chicago, IL 60611 USA

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2001年 / 51卷 / 04期

关键词：

inhibitory quotient; pharmacoenhancement; protease inhibitors; therapeutic drug monitoring;

D O I：

10.1046/j.1365-2125.2001.01380.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：301 / 308

页数：8

共 44 条

[21] Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens [J].

Havlir, DV ;

Hellmann, NS ;

Petropoulos, CJ ;

Whitcomb, JM ;

Collier, AC ;

Hirsch, MS ;

Tebas, P ;

Sommadossi, JP ;

Richman, DD .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (02) :229-234

[22] The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy [J].

Hoetelmans, RMW ;

Reijers, MHE ;

Weverling, GJ ;

ten Kate, RW ;

Wit, FWNM ;

Mulder, JW ;

Weigel, HM ;

Frissen, PHJ ;

Roos, M ;

Jurriaans, S ;

Schuitemaker, H ;

de Wolf, F ;

Beijnen, JH ;

Lange, JMA .

AIDS, 1998, 12 (11) :F111-F115

[23]

Huisman MT, 2000, AIDS, V14, P237, DOI 10.1097/00002030-200002180-00005

[24]

KHALIQ Y, 1999, 6 C RETR OPP INF CHI

[25] The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors [J].

Kim, RB ;

Fromm, MF ;

Wandel, C ;

Leake, B ;

Wood, AJJ ;

Roden, DM ;

Wilkinson, GR .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :289-294

[26] Ritonavir [J].

Lea, AP ;

Faulds, D .

DRUGS, 1996, 52 (04) :541-546

[27] Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study [J].

Ledergerber, B ;

Egger, M ;

Opravil, M ;

Telenti, A ;

Hirschel, B ;

Battegay, M ;

Vernazza, P ;

Sudre, P ;

Flepp, M ;

Furrer, H ;

Francioli, P ;

Weber, R .

LANCET, 1999, 353 (9156) :863-868

[28] HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter [J].

Lee, CGL ;

Gottesman, MM ;

Cardarelli, CO ;

Ramachandra, M ;

Jeang, KT ;

Ambudkar, SV ;

Pastan, I ;

Dey, S .

BIOCHEMISTRY, 1998, 37 (11) :3594-3601

[29]

MARKOWITZ M, 1995, NEW ENGL J MED, V333, P1534, DOI 10.1056/NEJM199512073332304

[30]

Merry C, 1996, BRIT J CLIN PHARMACO, V42, P787

← 1 2 3 4 5 →